Geriatric Healthcare Specialist New Haven CT

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment.

Slawomir Mejnartowicz
(203) 432-0076
17 Hillhouse Ave
New Haven, CT
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Denise A Ross, MD
(203) 737-4043
PO Box 208041
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Pa Sch Of Med, Philadelphia Pa 19104
Graduation Year: 1980

Data Provided by:
Lynn Adele Street, MD
(203) 498-7730
142 Huntington St
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1987

Data Provided by:
John Augustus Merritt
(203) 789-4150
1450 Chapel St
New Haven, CT
Specialty
Geriatric Medicine

Data Provided by:
Aanand Dinkar Naik, MD
PO Box 208025
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Male
Education
Medical School: Univ Of Tx Southwestern Med Ctr At Dallas, Med Sch, Dallas Tx 75235
Graduation Year: 1998

Data Provided by:
Sharon Kiyomi Inouye, MD
(203) 688-7302
PO Box 208025
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Ca, San Francisco, Sch Of Med, San Francisco Ca 94143
Graduation Year: 1981

Data Provided by:
Grace Yin Jenq, MD
20 York St
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Johns Hopkins Univ Sch Of Med, Baltimore Md 21205
Graduation Year: 1997

Data Provided by:
Gerard Joseph Kerins
(203) 789-3022
1450 Chapel St
New Haven, CT
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Susan E Hardy, MD
(203) 688-8479
904 1/2 State St
New Haven, CT
Specialties
Geriatrics, Geriatric Medicine-Internal Medicine
Gender
Female
Education
Medical School: Univ Of Pittsburgh Sch Of Med, Pittsburgh Pa 15261
Graduation Year: 1996

Data Provided by:
Roula Gaby Rizk
(203) 789-4074
1450 Chapel St
New Haven, CT
Specialty
Internal Medicine, Geriatric Medicine

Data Provided by:
Data Provided by:

Food for Thought

Provided by: 

By Kris Kucera

Rarely does an extended family get a free pass from Alzheimer’s disease or diabetes mellitus. On the surface, these two afflictions appear totally unrelated —Alzheimer’s (AD), Mother Nature’s cruel version of identity theft; and diabetes, the glucose-metabolism disorder that affects both young and old alike. However, new research indicates that the two diseases behave in a similar manner.

In a study recently published in the Journal of Alzheimer’s Disease, researchers from Brown Medical School found that reduced glucose uptake and decreased metabolism in the hippocampus—the area of the brain associated with memory—cause neurodegeneration and cognitive impairment. This, they say, suggests that a form of diabetes, tentatively dubbed type 3, leads to AD.

Type 1 diabetes results from a severe or complete lack of insulin, a hormone made in the pancreas that controls blood sugar. Type 2, dubbed adult onset diabetes (although these days it occurs in teenagers and even younger kids), also stems from a dearth of insulin, or insulin resistance —the existing insulin molecules cannot deliver glucose through the cells’ membranes. Surprisingly, the researchers found a new form of insulin, produced in the brain, and they believe that, over time, decreasing levels of this “brain insulin” and other insulin-related proteins ultimately precipitate AD. While levels of brain insulin have no known affect on a body’s overall blood sugar, scientists have long recognized that diabetes patients are more likely to develop AD than those without the disease.

Skeptics of the Brown team’s findings argue that our brains produce so little insulin in the first place, reduced levels of the hormone can’t possibly play a significant role in AD. Regardless, the new data show that AD may be a neuroendocrine disorder, thus increasing the possibility for more effective treatments. And that gives hope to all of us who may one day be touched, directly or indirectly, by the merciless hand of AD.

Copyright 1999-2009 Natural Solutions: Vibrant Health, Balanced Living/Alternative Medicine/InnoVisi...

Click here to read more from Natural Solutions